Cargando…
SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline “S2P” spike—widely employed for laboratory work and clinical studies—unfolds when stored...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393506/ https://www.ncbi.nlm.nih.gov/pubmed/34461095 http://dx.doi.org/10.1016/j.jbc.2021.101127 |
_version_ | 1783743741843996672 |
---|---|
author | Olia, Adam S. Tsybovsky, Yaroslav Chen, Steven J. Liu, Cuiping Nazzari, Alexandra F. Ou, Li Wang, Lingshu Kong, Wing-Pui Leung, Kwan Liu, Tracy Stephens, Tyler Teng, I-Ting Wang, Shuishu Yang, Eun Sung Zhang, Baoshan Zhang, Yi Zhou, Tongqing Mascola, John R. Kwong, Peter D. |
author_facet | Olia, Adam S. Tsybovsky, Yaroslav Chen, Steven J. Liu, Cuiping Nazzari, Alexandra F. Ou, Li Wang, Lingshu Kong, Wing-Pui Leung, Kwan Liu, Tracy Stephens, Tyler Teng, I-Ting Wang, Shuishu Yang, Eun Sung Zhang, Baoshan Zhang, Yi Zhou, Tongqing Mascola, John R. Kwong, Peter D. |
author_sort | Olia, Adam S. |
collection | PubMed |
description | The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline “S2P” spike—widely employed for laboratory work and clinical studies—unfolds when stored at 4 °C, physiological pH, as observed by electron microscopy (EM) and differential scanning calorimetry, but that its trimeric, native-like conformation can be reacquired by low pH treatment. When stored for approximately 1 week, this unfolding does not significantly alter antigenic characteristics; however, longer storage diminishes antibody binding, and month-old spike elicits virtually no neutralization in mice despite inducing high ELISA-binding titers. Cryo-EM structures reveal the folded fraction of spike to decrease with aging; however, its structure remains largely similar, although with varying mobility of the receptor-binding domain. Thus, the SARS-CoV-2 spike is susceptible to unfolding, which affects immunogenicity, highlighting the need to monitor its integrity. |
format | Online Article Text |
id | pubmed-8393506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83935062021-08-27 SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity Olia, Adam S. Tsybovsky, Yaroslav Chen, Steven J. Liu, Cuiping Nazzari, Alexandra F. Ou, Li Wang, Lingshu Kong, Wing-Pui Leung, Kwan Liu, Tracy Stephens, Tyler Teng, I-Ting Wang, Shuishu Yang, Eun Sung Zhang, Baoshan Zhang, Yi Zhou, Tongqing Mascola, John R. Kwong, Peter D. J Biol Chem Research Article The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline “S2P” spike—widely employed for laboratory work and clinical studies—unfolds when stored at 4 °C, physiological pH, as observed by electron microscopy (EM) and differential scanning calorimetry, but that its trimeric, native-like conformation can be reacquired by low pH treatment. When stored for approximately 1 week, this unfolding does not significantly alter antigenic characteristics; however, longer storage diminishes antibody binding, and month-old spike elicits virtually no neutralization in mice despite inducing high ELISA-binding titers. Cryo-EM structures reveal the folded fraction of spike to decrease with aging; however, its structure remains largely similar, although with varying mobility of the receptor-binding domain. Thus, the SARS-CoV-2 spike is susceptible to unfolding, which affects immunogenicity, highlighting the need to monitor its integrity. American Society for Biochemistry and Molecular Biology 2021-08-27 /pmc/articles/PMC8393506/ /pubmed/34461095 http://dx.doi.org/10.1016/j.jbc.2021.101127 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Olia, Adam S. Tsybovsky, Yaroslav Chen, Steven J. Liu, Cuiping Nazzari, Alexandra F. Ou, Li Wang, Lingshu Kong, Wing-Pui Leung, Kwan Liu, Tracy Stephens, Tyler Teng, I-Ting Wang, Shuishu Yang, Eun Sung Zhang, Baoshan Zhang, Yi Zhou, Tongqing Mascola, John R. Kwong, Peter D. SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity |
title | SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity |
title_full | SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity |
title_fullStr | SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity |
title_full_unstemmed | SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity |
title_short | SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity |
title_sort | sars-cov-2 s2p spike ages through distinct states with altered immunogenicity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393506/ https://www.ncbi.nlm.nih.gov/pubmed/34461095 http://dx.doi.org/10.1016/j.jbc.2021.101127 |
work_keys_str_mv | AT oliaadams sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT tsybovskyyaroslav sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT chenstevenj sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT liucuiping sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT nazzarialexandraf sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT ouli sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT wanglingshu sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT kongwingpui sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT leungkwan sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT liutracy sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT stephenstyler sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT tengiting sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT wangshuishu sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT yangeunsung sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT zhangbaoshan sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT zhangyi sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT zhoutongqing sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT mascolajohnr sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity AT kwongpeterd sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity |